Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Hemodialysis on Serum Sclerostin Levels in Diabetic Patients With Chronic Renal Failure

NCT03952819 is registered in ClinicalTrials.gov with Abant Izzet Baysal University as lead sponsor.

NCT NCT03952819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03952819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Hemodialysis on Serum Sclerostin Levels in Diabetic Patients With Chronic Renal Failure
Lead sponsor
Abant Izzet Baysal University
Phase
Observational
Overall status
Completed
Start date
September 14, 2017
Completion date
December 15, 2018
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, hemodialysis access failure, renal failure